The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception

CompletedOBSERVATIONAL
Enrollment

316

Participants

Timeline

Start Date

February 21, 2021

Primary Completion Date

January 12, 2023

Study Completion Date

May 4, 2023

Conditions
Hormonal Intrauterine Contraception
Interventions
DRUG

Low-dose levonorgestrel intrauterine systems (LNG-IUS)

Any low-dose intrauterine system (IUS) marketed in Spain

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY